[HTML][HTML] Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac, IK Vojtusek, L Grgurevic - Bioengineering, 2023 - mdpi.com
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac… - Bioengineering …, 2023 - pubmed.ncbi.nlm.nih.gov
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

[PDF][PDF] Revisiting the Role of NAG across the Continuum of Kidney Disease. Bioengineering 2023, 10, 444

R Novak, G Salai, S Hrkac, IK Vojtusek, L Grgurevic - 2023 - bib.irb.hr
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac, I Vojtusek… - Bioengineering (Basel …, 2023 - europepmc.org
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

[HTML][HTML] Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac, IK Vojtusek… - Bioengineering, 2023 - ncbi.nlm.nih.gov
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

[PDF][PDF] Revisiting the Role of NAG across the Continuum of Kidney Disease. Bioengineering 2023, 10, 444

R Novak, G Salai, S Hrkac, IK Vojtusek, L Grgurevic - 2023 - researchgate.net
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkač, I Kovačević Vojtušek… - Bioengineering, 2023 - croris.hr
Sažetak Acute and chronic kidney diseases are an evolving continuum for which reliable
biomarkers of early disease are lacking. The potential use of glycosidases, enzymes …

Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac, IK Vojtusek, L Grgurevic - Bioengineering, 2023 - cir.nii.ac.jp
抄録< jats: p> Acute and chronic kidney diseases are an evolving continuum for which
reliable biomarkers of early disease are lacking. The potential use of glycosidases, enzymes …

Revisiting the Role of NAG across the Continuum of Kidney Disease.

R Novak, G Salai, S Hrkac, IK Vojtusek… - Bioengineering …, 2023 - search.ebscohost.com
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …

Revisiting the Role of NAG across the Continuum of Kidney Disease

R Novak, G Salai, S Hrkac, IK Vojtusek, L Grgurevic - Bioengineering, 2023 - agris.fao.org
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers
of early disease are lacking. The potential use of glycosidases, enzymes involved in …